Life sciences organizations operate under some of the most demanding regulatory expectations in any industry. Clinical trial data, patient information, manufacturing records, and proprietary research represent enormous scientific, financial, and human value. As the industry accelerates its adoption of cloud platforms, intelligent automation, and artificial intelligence, the number of external partners touching that data is growing quickly.
That growth creates a question every life sciences leader must answer: how do you know your technology partners are protecting what matters most? SOC 2 has become a critical part of that answer.
Key Takeaways
- SOC 2 complements GxP validation. It does not replace it.
- Six SOC 2 control areas map directly to life sciences priorities, from attributable records to supplier qualification.
- A SOC 2 Type II report can be added to supplier qualification files and referenced during inspections.
- AI partners in regulated workflows should show evidence on data use, model change control, data lineage, and subprocessor governance.
What Data Do Life Sciences Organizations Need to Protect?
Few industries manage data as sensitive or as heavily scrutinized. Pharma, biotech, CRO, and medical device organizations routinely handle:
- Clinical trial and patient data subject to HIPAA, GDPR, and other privacy regulations
- GxP records that must meet data integrity expectations, including ALCOA+ principles
- Electronic records and signatures governed by 21 CFR Part 11 and EU Annex 11
- Proprietary research, formulations, and intellectual property
- Manufacturing and quality data that directly affects product safety
A single compromise can delay a submission, trigger a regulatory finding, damage sponsor relationships, or put patients at risk.
Where Does SOC 2 Fit Alongside GxP?
SOC 2 does not replace GxP validation, Computer Software Assurance, or regulatory compliance obligations. It complements them.
GxP frameworks focus on whether systems are fit for intended use and whether data is reliable for regulatory decision making. SOC 2, defined by the AICPA Trust Services Criteria, focuses on whether the organization operating those systems has effective controls over security, availability, confidentiality, processing integrity, and privacy.
Together, they give quality, IT, and procurement leaders a more complete picture of vendor risk. A partner with both GxP experience and SOC 2 controls can demonstrate that systems are validated and that the environment surrounding those systems is secure and well governed.
Several SOC 2 control areas map closely to life sciences priorities:
- Access controls support the attributability and security of regulated records.
- Change management supports controlled, documented, and traceable system changes.
- Processing integrity supports accurate and complete data handling.
- Availability controls support business continuity for critical operations.
- Vendor and subprocessor management supports supplier qualification expectations.
- Incident response supports timely detection and escalation of events affecting regulated data.
How Does SOC 2 Support Supplier Qualification and Audit Readiness?
Regulators expect life sciences organizations to qualify and oversee their suppliers. Quality teams often conduct audits, issue questionnaires, and review evidence before approving a technology partner.
A SOC 2 Type II report can significantly streamline this process. It provides independent evidence of control effectiveness over time, which can be incorporated into supplier qualification files and referenced during inspections. It does not eliminate the need for life sciences specific assessment, but it gives quality teams a credible, verified foundation to build on. For the difference between Type I and Type II reports, see why SOC 2 is valuable when choosing your vendors.
Why Does AI Raise the Stakes?
AI adoption across life sciences is moving from pilots to production. Organizations are applying AI to clinical operations, pharmacovigilance, regulatory writing, laboratory workflows, manufacturing, quality management, and commercial operations.
Each of these use cases raises governance questions that regulators are actively addressing. FDA has issued guidance on the use of AI to support regulatory decision making, the EU AI Act introduces risk-based obligations, and industry groups continue to define good practice for AI in GxP environments.
For AI partners, SOC 2 controls help answer questions that life sciences leaders are now asking routinely:
- Where is our data stored, and who can access it?
- Is our data used to train models that serve other customers?
- How are model changes controlled and documented?
- How is data lineage maintained from source to output?
- How are third-party model and cloud providers governed?
- Can the vendor support our audit and inspection needs?
An AI partner that cannot answer these questions with evidence introduces risk that no amount of innovation can offset.
What Should Life Sciences Leaders Look For in a Technology Partner?
- A current SOC 2 Type II report with scope that covers the services you are procuring
- Demonstrated experience in GxP and regulated environments
- Clear data handling, segregation, and retention practices
- Documented AI governance, including model change control and human oversight
- Willingness to support supplier audits and provide quality documentation
- Transparent subprocessor management
The Bottom Line
In life sciences, trust is not a soft concept. It is documented, audited, and inspected. SOC 2 gives decision makers an independent, standardized way to verify that a technology partner takes data protection as seriously as the industry requires. As AI becomes embedded in regulated workflows, that verification is no longer optional. It is a baseline expectation.
Veritas Automata maintains SOC 2 compliance and supports supplier qualification for life sciences and healthcare customers. See our security and trust practices.
Frequently Asked Questions About SOC 2 in Life Sciences
Does SOC 2 replace GxP validation?
No. SOC 2 does not replace GxP validation, Computer Software Assurance, or regulatory compliance obligations. GxP shows a system is fit for intended use and its data is reliable. SOC 2 shows the organization running the system has effective security, availability, confidentiality, processing integrity, and privacy controls.
How does a SOC 2 report help with supplier qualification?
A SOC 2 Type II report gives quality teams independent evidence that a technology partner’s controls worked over time. It can go into supplier qualification files and be referenced during inspections, though life sciences specific assessment is still needed.
Which SOC 2 controls matter most to life sciences companies?
Access controls, change management, processing integrity, availability, vendor and subprocessor management, and incident response. These map to attributable records, traceable system changes, accurate data handling, business continuity, supplier oversight, and escalation of events affecting regulated data.
What should life sciences leaders ask an AI partner about data?
Where data is stored and who can access it, whether it trains models used by other customers, how model changes are controlled, how data lineage is kept from source to output, how third-party model and cloud providers are governed, and whether the vendor supports audits and inspections.
Sources
Qualifying a Technology Partner?
Our SOC 2 documentation is available to customers and qualified prospects under a nondisclosure agreement.
Request the report and our team will follow up with the NDA and supporting quality documentation.
